Dark PoolEvent Sunday, June 15, 2025Analyzed

Odyssey Therapeutics LLC Series C

Bullish

Summary

Odyssey Therapeutics LLC raised $66.8M in a Series C Form D filing on 2026-06-02, with first sale on 2025-06-15. The company operates in Strategic Defense Technology, attracting investment from notable firms Andreessen Horowitz and Y Combinator.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Full Analysis

### Executive Summary Odyssey Therapeutics LLC raised $66.8M in a Series C Form D filing on 2026-06-02, with first sale on 2025-06-15. The company operates in Strategic Defense Technology, attracting investment from notable firms Andreessen Horowitz and Y Combinator. ### Investor Edge Watch for a potential D/A amendment, which could indicate additional capital closed or changes in terms, providing a clearer signal of momentum. ### Sector capital positioning Defense technology continues to see strong capital inflows, with this $66.8M Series C signaling sustained investor confidence in the sector. ### Convergence Signals No convergence signals are directly apparent from the filing; no public contracts, patents, or legislation links are provided. ### Key Takeaways - Odyssey Therapeutics raised $66.8M in Series C, a significant round for a private defense tech company. - Backed by top-tier investors Andreessen Horowitz and Y Combinator, indicating strong institutional confidence. - The company's name and industry (Strategic Defense Technology) show a potential pivot or misclassification worth monitoring. ### Risk Indicators & Flags The industry classification 'Strategic Defense Technology' is incongruent with the company name 'Therapeutics', raising potential misclassification or strategic pivot concerns. No state disclosure limits jurisdictional assessment. ### Verification & References Verify filing via SEC EDGAR using accession number 0001702600-24-001028. Company: Odyssey Therapeutics LLC Series C; form type D; capital raised $66.8M; related persons: Andreessen Horowitz, Y Combinator.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderJun 2, 2026

Promoting Advanced Artificial Intelligence Innovation and Security

This executive order directs multiple federal agencies to prioritize cybersecurity hardening of national security, Department of War, and civilian government systems within 30 days. It establishes a classified benchmarking process for 'covered frontier models' and a voluntary framework for AI developers to provide early access to such models to the government for cybersecurity purposes. It also creates an AI cybersecurity clearinghouse, expands cybersecurity hiring pathways, and directs enforcement against AI-enabled computer crimes.

presidential_memorandumMay 29, 2026

Approving Critical Position Pay Authority for National Security Investment Workforce

This memorandum authorizes the Office of Personnel Management to allocate up to 400 critical positions with pay up to $400,000 to recruit specialized talent for national security investment programs, focusing on critical minerals, advanced materials, and strategic supply chains. It directs OPM and OMB to oversee allocation and ensure pay is used only to recruit or retain exceptionally qualified individuals. The action aims to accelerate domestic mineral production and reduce foreign dependence.

Exec OrderMay 19, 2026

Integrating Financial Technology Innovation into Regulatory Frameworks

This executive order directs federal financial regulators to review and streamline regulations that hinder fintech innovation, particularly for small and emerging firms, and requests the Federal Reserve to evaluate expanding access to its payment accounts and services for non-bank and digital asset firms. It aims to reduce barriers to entry and encourage partnerships between fintech firms and traditional financial institutions, with specific deadlines for reviews and reports.